14 articles, transcripts, and reports
Biocept (NASDAQ: BIOC) reported a narrower loss in the second quarter of 2020. The company’s revenue declined by 23% year-over-year to $917,000, hurt by the…
Investing in microcap stocks are considered to be risky; even higher so in uncertain market environments like the one we are seeing right now. So…
Biocept Inc. (BIOC) Q1 2020 earnings call dated May 13, 2020 Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief…
Biocept, Inc. (NASDAQ: BIOC) reported a narrower loss in the fourth quarter of 2019 driven by higher revenue. The bottom line was wider than the…
